Clinical Consultations and Investigations Before and After Discontinuation of Endocrine Therapy in Women with Primary Breast Cancer

This academic paper explores the reasons why women with hormone dependent primary breast cancer discontinue endocrine therapy, despite the fact it is recommended treatment for up to 5 years post treatment for cancer.

Author(s): Derrick Lopez, Anna Kemp-Casey, Christobel Saunders, Elizabeth Roughead, Frances Boyle, Max Bulsara, David Preen
Organisation: Public Health Research & Practice
Year Published: 2017
Language: English

Australian Women’s Health Alliance acknowledges the owners of the lands on which we live and work, and pay our respect to Elders past and present. We recognise First Nations people across this country and their continuing connection to land, waters, and culture. Sovereignty has not been ceded.

Have a health concern?

Call healthdirect – 1800 022 222

Experiencing violence?

Contact 1800RESPECT

Is it an emergency?

Call triple zero – 000

Other crisis and general helplines can also be found online

Want to yarn with an Aboriginal or Torres Strait Islander Crisis Supporter?

Call 13YARN – 13 92 76

Looking for LGBTIQ+ support?

Contact QLife – 1800 184 527

Australian Women’s Health Alliance acknowledges the support of the Australian Government. The Women’s Health Hub project is funded by the Australian Government Department of Health and Aged Care, Health Peak Advisory Bodies Program.

This website contains names and images of people who have died.

Website Maintained by SME Digital